newsfilter
← Latest News
PR Newswire·

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the...